Effect of zinc in treatment of gestational diabetes

Phase 2

• Conditions: Gestational diabetes.; Diabetes mellitus in pregnancy, unspecified; O24.9

• Registration Number: IRCT201505095623N42
• Lead Sponsor: Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 50

Inclusion Criteria

Pregnant women aged 18-40 years
diagnosed with GDM at 24-28 weeks' gestation

Exclusion Criteria

The use of substitute treatments including hormone or vitamin supplements
patients with preeclampsia
complete bed rest (CBR)
intra uterine fetal death (IUFD)
placenta abruption
preterm delivery

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hs-CRP. Timepoint: Baseline and End-of-trial. Method of measurement: Elisa.;Newborns PPAR-gamma. Timepoint: Cord blood of newborns of women with GDM at delivery time. Method of measurement: PCR-RT.

Secondary Outcome Measures

Name	Time	Method
Total antioxidant capacity. Timepoint: Baseline and End-of-trial. Method of measurement: Spectrophotometry.;Nitric oxide. Timepoint: Baseline and End-of-trial. Method of measurement: Spectrophotometry.;Glutathione. Timepoint: Baseline and End-of-trial. Method of measurement: Spectrophotometry.;Newborns' weight. Timepoint: The first 24 h after birth. Method of measurement: Scale.;Newborn length. Timepoint: The first 24 h after birth. Method of measurement: Girth measuring tape.;Newborn head circumference. Timepoint: The first 24 h after birth. Method of measurement: Girth measuring tape.;Polyhydramnios. Timepoint: Post-intervention. Method of measurement: Sonography.;Newborns GLUT. Timepoint: Cord blood of newborns of women with GDM at delivery time. Method of measurement: PCR-RT.